Delivery Order SPE2DB22D1202-SPE2DB25FVJM7
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $6.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,248.08 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injectors on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, addressing pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,480.15 on November 17, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector units. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy administered via...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,444.99 on June 3, 2025, for the supply of Xyosted 100 mg/0.5 ml auto-injectors (0.5 ml). This firm fixed-price, competitively awarded delivery order is scheduled for ultimate completion on June 4, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible vendors. Xyosted is...
- The Defense Logistics Agency awarded a $2,205.54 delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injectors on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injection, representing part of the...
- The Defense Logistics Agency awarded a $1,752.22 delivery order to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injectors on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken, Pennsylvania facility. Xyosted is a testosterone replacement therapy medication delivered via auto-injector, reflecting the Defense...
- The Defense Logistics Agency awarded a $1,317.52 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for Xyosted 50 mg/0.5 mL auto-injector units with a completion date of June 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, supporting the agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with a ceiling value of $1,314.73 under a firm fixed-price arrangement. The contract was competitively awarded without set-aside provisions and is due for completion by September 9, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,871.34 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 17, 2025. The award was issued on October 16, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $9,466.20 to AmerisourceBergen Drug Corp for the supply of Xyosted 100 mg/0.5 mL auto-injectors on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy delivered via subcutaneous...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies, valued at $1,500.30 with an ultimate completion date of October 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...